The ability to make a large variety of virus-like particles (VLPs) has been successfully achieved in the baculovirus expression vector system (BEVS)/insect cell system. The production and scale-up of these particles, which are mostly sought as vaccine candidates, are currently being addressed. Furthermore, these VLPs are being investigated as delivery agents for use as therapeutics. The use of host insect cells allows mass production of VLPs in a proven scalable system.
CITATION STYLE
Thompson, C. M., Aucoin, M. G., & Kamen, A. A. (2016). Production of virus-like particles for vaccination. In Methods in Molecular Biology (Vol. 1350, pp. 299–315). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3043-2_14
Mendeley helps you to discover research relevant for your work.